NAMPT
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
CSN16533 | STF-118804 | 894187-61-2 | STF-118804 is a highly specific and potent NAMPT inhibitor with IC50 values of 3-6 nM |
CSN17983 | KPT 9274 ( ATG-019) | 1643913-93-2 | PAK4-IN-1 is an inhibitor of p21-activated kinases PAKs with IC50 of 100 nM in MTT assay |
CSN16934 | P7C3 | 301353-96-8 | P7C3 is a brain-penetrant NAMPT activator with proneurogenic and neuroprotective effect |
CSN17999 | Nampt-IN-1 | 1698878-14-6 | Nampt-IN-1 is an inhibitor of NAMPT with IC50 of 18 nM NCI-H1155 cell 49 nM Calu-6 cell 333 nM HCC1937 cell and 389 nM MCF-7 cell respectively |
CSN17752 | GNE-617 | 1362154-70-8 | GNE-617 is a potent NAMPT inhibitor with IC50 value of 5nM |
CSN19050 | GNE-617 hydrochloride | 2070014-99-0 | GNE-617 HCl is a specific NAMPT inhibitor that inhibits the biochemical activity of NAMPT with an IC50 of 5 nM and exhibits efficacy in xenograft models of cancer. |
CSN16223 | CHS-828 | 200484-11-3 | GMX1778 is a competitive NAMPT nicotinamide phosphoribosyltransferase inhibitor |
CSN16330 | (E)-Daporinad | 658084-64-1 | FK866 effectively inhibits nicotinamide phosphoribosyltransferase (NMPRTase) with IC50 of 0.09 nM in a cell-free assay. |
CSN18096 | CB30865 | 206275-15-2 | CB30865 is a potent inhibitor of NAMPT an enzyme present in the NAD biosynthetic pathway |
CSN18183 | CB 300919 | 289715-28-2 | CB-300919 is a water-soluble analogue of CB30865 a potent inhibitor of nicotinamide phosphoribosyltransferase Nampt and has a continuous exposure96 h growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft |
CSN20326 | A-1293201 | 1375557-33-7 | A-1293201 is a non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase NAMPT with nanomolar antiproliferative activity and preclinical pharmacokinetics properties which enabled potent antitumor activity when dosed orally in mouse xenograft models |